Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During Percutaneous Coronary Intervention: an Optical Coherence Tomography Study

Trial Profile

Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During Percutaneous Coronary Intervention: an Optical Coherence Tomography Study

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 22 Dec 2016

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes; Coronary artery disease; Embolism and thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Dec 2016 Status changed from discontinued to withdrawn prior to enrolment.
    • 27 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 30 Jan 2014 According to ClinicalTrials.gov record planned end date changed from 1 Aug 2014 to 1 Dec 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top